Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action

References

• Thummel KE O’Shea D Paine MF Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism Clin Pharmacol Ther 1996 59 5 491 502 8646820
   PubMed Web of Science ®Google Scholar
• Nordt SP Clark RF Midazolam: a review of therapeutic uses and toxicity J Emerg Med 1997 15 3 357 365 9258787
   PubMedGoogle Scholar
• Nonaka A Kashimoto S Imamura M Furuya A Kumazawa T Mechanism of the negative inotropic effect of midazolam and diazepam in cultured foetal mouse cardiac myocytes Eur J Anaesthesiol 1997 14 5 481 487 9303284
   PubMed Web of Science ®Google Scholar
• Study RE Barker JL Diazepam and (–)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons Proc Natl Acad Sci U S A 1981 78 11 7180 7184 6273918
   PubMed Web of Science ®Google Scholar
• Morani G Bergamini C Angheben C General anaesthesia for external electrical cardioversion of atrial fibrillation: experience of an exclusively cardiological procedural management Europace 2010 12 11 1558 1563 20713490
   PubMed Web of Science ®Google Scholar
• Wutzler A Loehr L Huemer M Deep sedation during catheter ablation for atrial fibrillation in elderly patients J Interv Card Electrophysiol 2013 38 2 115 121 24013702
   PubMed Web of Science ®Google Scholar
• Wutzler A Mueller A Loehr L Minimal and deep sedation during ablation of ventricular tachycardia Int J Cardiol 2014 172 1 161 164 24447761
   PubMed Web of Science ®Google Scholar
• Hüneke R Fassl J Rossaint R Lückhoff A Effects of volatile anesthetics on cardiac ion channels Acta Anaesthesiol Scand 2004 48 5 547 561 15101848
   PubMed Web of Science ®Google Scholar
• Staikou C Stamelos M Stavroulakis E Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity Br J Anaesth 2014 112 2 217 230 24305646
   PubMed Web of Science ®Google Scholar
• Miró O de la Red G Fontanals J Cessation of paroxysmal atrial fibrillation during acute intravenous propofol administration Anesthesiology 2000 92 3 910 10719989
   PubMed Web of Science ®Google Scholar
• Michaloudis DG Kanakoudis FS Petrou AM Konstantinidou AS Pollard BJ The effects of midazolam or propofol followed by suxamethonium on the QT interval in humans Eur J Anaesthesiol 1996 13 4 364 368 8842657
   PubMed Web of Science ®Google Scholar
• Buljubasic N Marijic J Berczi V Supan DF Kampine JP Bosnjak ZJ Differential effects of etomidate, propofol, and midazolam on calcium and potassium channel currents in canine myocardial cells Anesthesiology 1996 85 5 1092 1099 8916827
   PubMed Web of Science ®Google Scholar
• So EC Wu KC Kao FC Wu SN Effects of midazolam on ion currents and membrane potential in differentiated motor neuron-like NSC-34 and NG108-15 cells Eur J Pharmacol 2014 724 152 160 24374009
   PubMed Web of Science ®Google Scholar
• Nerbonne JM Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium J Physiol 2000 525 Pt 2 285 298 10835033
   PubMed Web of Science ®Google Scholar
• Kanto JH Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia Pharmacotherapy 1985 5 3 138 155 3161005
   PubMed Web of Science ®Google Scholar
• Feng J Wible B Li GR Wang Z Nattel S Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes Circ Res 1997 80 4 572 579 9118489
   PubMed Web of Science ®Google Scholar
• Wettwer E Hála O Christ T Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation Circulation 2004 110 16 2299 2306 15477405
   PubMed Web of Science ®Google Scholar
• Li GR Feng J Yue L Carrier M Nattel S Evidence for two components of delayed rectifier K+ current in human ventricular myocytes Circ Res 1996 78 4 689 696 8635226
   PubMed Web of Science ®Google Scholar
• Tibbs GR Rowley TJ Sanford RL HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain J Pharmacol Exp Ther 2013 345 3 363 373 23549867
   PubMed Web of Science ®Google Scholar
• López-Izquierdo A Ponce-Balbuena D Ferrer T Rodríguez-Menchaca AA Sánchez-Chapula JA Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism Eur J Pharmacol 2010 638 1–3 33 41 20447386
   PubMed Web of Science ®Google Scholar
• Fischer F Vonderlin N Zitron E Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action Naunyn Schmiedebergs Arch Pharmacol 2013 386 11 991 999 23832378
   PubMed Web of Science ®Google Scholar
• Fischer F Vonderlin N Seyler C Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels Naunyn Schmiedebergs Arch Pharmacol 2013 386 9 795 804 23666493
   PubMed Web of Science ®Google Scholar
• Scholz EP Konrad FM Weiss DL Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656 Naunyn Schmiedebergs Arch Pharmacol 2007 376 4 275 284 17965852
   PubMed Web of Science ®Google Scholar
• Scholz EP Alter M Zitron E In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform Toxicol Lett 2006 165 2 156 166 16647228
   PubMed Web of Science ®Google Scholar
• Zitron E Scholz E Owen RW QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids Circulation 2005 111 7 835 838 15710766
   PubMed Web of Science ®Google Scholar
• Madeja M Musshoff U Speckmann EJ Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis Eur J Neurosci 1997 9 3 599 604 9104601
   PubMed Web of Science ®Google Scholar
• Yamakage M Matsuzaki T Tsujiguchi N Honma Y Namiki A Inhibitory effects of diazepam and midazolam on Ca2+ and K+ channels in canine tracheal smooth muscle cells Anesthesiology 1999 90 1 197 207 9915329
   PubMed Web of Science ®Google Scholar
• Reves JG Fragen RJ Vinik HR Greenblatt DJ Midazolam: pharmacology and uses Anesthesiology 1985 62 3 310 324 3156545
   PubMed Web of Science ®Google Scholar
• Crevat-Pisano P Dragna S Granthil C Coassolo P Cano JP Francois G Plasma concentrations and pharmacokinetics of midazolam during anaesthesia J Pharm Pharmacol 1986 38 8 578 582 2876073
   PubMed Web of Science ®Google Scholar
• Persson P Nilsson A Hartvig P Tamsen A Pharmacokinetics of midazolam in total i.v. anaesthesia Br J Anaesth 1987 59 5 548 556 3580236
   PubMed Web of Science ®Google Scholar
• Dundee JW Halliday NJ Harper KW Brogden RN Midazolam. A review of its pharmacological properties and therapeutic use Drugs 1984 28 6 519 543 6394264
   PubMed Web of Science ®Google Scholar
• Wandel C Böcker R Böhrer H Browne A Rügheimer E Martin E Midazolam is metabolized by at least three different cytochrome P450 enzymes Br J Anaesth 1994 73 5 658 661 7826796
   PubMed Web of Science ®Google Scholar
• Kulka PJ Lauven PM Schüttler J Apffelstaedt C Methohexital vs midazolam/flumazenil anaesthesia during laryngoscopy under jet ventilation Acta Anaesthesiol Scand Suppl 1990 92 90 95 discussion 107 2109477
   PubMedGoogle Scholar
• Decher N Kumar P Gonzalez T Pirard B Sanguinetti MC Binding site of a novel Kv1.5 blocker: a “foot in the door” against atrial fibrillation Mol Pharmacol 2006 70 4 1204 1211 16835355
   PubMed Web of Science ®Google Scholar
• Decher N Pirard B Bundis F Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels J Biol Chem 2004 279 1 394 400 14578345
   PubMed Web of Science ®Google Scholar